VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,720,447 | -21.5% | 1,703,413 | +1.0% | 0.48% | -20.9% |
| Q2 2023 | $2,193,018 | +25.0% | 1,686,937 | 0.0% | 0.61% | +19.3% |
| Q1 2023 | $1,754,414 | +2.0% | 1,686,937 | 0.0% | 0.51% | -6.4% |
| Q4 2022 | $1,720,676 | -24.8% | 1,686,937 | +1.7% | 0.55% | -40.5% |
| Q3 2022 | $2,288,000 | +4.5% | 1,658,199 | 0.0% | 0.92% | +9.8% |
| Q2 2022 | $2,189,000 | -66.2% | 1,658,199 | +2.5% | 0.84% | -57.4% |
| Q1 2022 | $6,473,000 | -60.7% | 1,618,199 | 0.0% | 1.96% | -57.5% |
| Q4 2021 | $16,489,000 | -37.0% | 1,618,199 | 0.0% | 4.62% | -41.9% |
| Q3 2021 | $26,166,000 | +24.5% | 1,618,199 | 0.0% | 7.95% | +28.1% |
| Q2 2021 | $21,020,000 | -32.7% | 1,618,199 | 0.0% | 6.21% | -39.5% |
| Q1 2021 | $31,231,000 | – | 1,618,199 | – | 10.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $6,473,000 | 1.96% |
| Affinity Asset Advisors, LLC | 1,374,098 | $5,496,000 | 0.88% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $4,123,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 720,161 | $2,881,000 | 0.41% |
| Rubric Capital Management LP | 2,107,000 | $8,428,000 | 0.30% |
| Long Focus Capital Management, LLC | 430,200 | $1,721,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 327,236 | $1,309,000 | 0.20% |
| Clearline Capital LP | 412,657 | $1,651,000 | 0.19% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $1,540,000 | 0.16% |
| Sio Capital Management, LLC | 102,049 | $408,000 | 0.14% |